Adapthealth corp. AHCO.US Overview

BetaUS StockHealthcare
(No presentation for AHCO)

AHCO AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

AHCO Current Performance

-2.72%

Adapthealth corp.

-1.83%

Avg of Sector

-0.40%

S&P500

AHCO Key Information

AHCO Revenue by Segments

AHCO Revenue by Segments

AHCO Revenue by Segments

Browsing restrictions can be lifted for a fee.

AHCO Net Income

AHCO Net Income

AHCO Net Income

Browsing restrictions can be lifted for a fee.

AHCO Cash Flow

AHCO Cash Flow

AHCO Cash Flow

Browsing restrictions can be lifted for a fee.

AHCO Profit Margin

AHCO Profit Margin

AHCO Profit Margin

Browsing restrictions can be lifted for a fee.

AHCO PE Ratio River

AHCO PE Ratio River

AHCO PE Ratio River

Browsing restrictions can be lifted for a fee.

AHCO Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

AHCO Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2024Q4
2024Q3
2024Q2
2024Q1

AHCO Profile

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.

Price of AHCO

AHCO FAQ

  • When is AHCO's latest earnings report released?

    The most recent financial report for Adapthealth corp. (AHCO) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating AHCO's short-term business performance and financial health. For the latest updates on AHCO's earnings releases, visit this page regularly.

  • What is the operating profit of AHCO?

    According to the latest financial report, Adapthealth corp. (AHCO) reported an Operating Profit of 23.17M with an Operating Margin of 2.98% this period, representing a decline of 54.15% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is AHCO's revenue growth?

    In the latest financial report, Adapthealth corp. (AHCO) announced revenue of 777.88M, with a Year-Over-Year growth rate of -1.84%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does AHCO have?

    As of the end of the reporting period, Adapthealth corp. (AHCO) had total debt of 2.1B, with a debt ratio of 0.47. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does AHCO have?

    At the end of the period, Adapthealth corp. (AHCO) held Total Cash and Cash Equivalents of 53.65M, accounting for 0.01 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does AHCO go with three margins increasing?

    In the latest report, Adapthealth corp. (AHCO) did not achieve the “three margins increasing” benchmark, with a gross margin of 15.5%%, operating margin of 2.98%%, and net margin of -0.9%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess AHCO's profit trajectory and future growth potential.

  • Is AHCO's EPS continuing to grow?

    According to the past four quarterly reports, Adapthealth corp. (AHCO)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.05. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of AHCO?

    Adapthealth corp. (AHCO)'s Free Cash Flow (FCF) for the period is -58K, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 99.85% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of AHCO?

    The latest valuation data shows Adapthealth corp. (AHCO) has a Price-To-Earnings (PE) ratio of 13.99 and a Price/Earnings-To-Growth (PEG) ratio of 0.44. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.